CVS Health Corp (CVS · NYSE)

CVS · MARKET VIEW

Market view · as of Jun 22, 2026

Revenue (TTM)
$405.62B
+6.1% YoY
Gross margin
13.4%
EPS (latest q)
$2.57
vs $2.21 est · beat
52-wk position
91.8%
-3.6% vs 52w high · +5.4% 1mo

Price (last ~year)

CVS Health Corp, a $125.45 billion healthcare provider, has exceeded earnings estimates for four consecutive quarters, most recently reporting $2.57 per share against a $2.21 forecast. The company generated $405.62 billion in trailing twelve-month revenue, though it carries $78.34 billion in total debt with a 5.1x debt-to-EBITDA ratio. Shares have risen 36.2% over the last three months as institutional investors adjust positions following the company's recent performance.

Valuation

Market cap
$125.45B
P/E
43.12
PEG
0.277
P/B
1.62
P/S
0.309
EV/EBITDA
17.25
Beta
0.623
Analyst target
$105

Quality & returns

Gross margin
13.4%
Operating margin
4.1%
Profit margin
0.7%
ROE
3.8%
ROA
2.7%

Price movement

Last
$98.32
1-month
+5.4%
3-month
+36.2%
RSI (14)
71
vs SMA200
+24.0%
52-wk position
91.8% -3.6% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$100.43B$4.68B$2.94B$5.83B
2025-12-31$105.69B$2.11B$2.94B$3.29B
2025-09-30$102.87B$-3.21B$-3.98B$-1.56B
2025-06-30$98.92B$2.38B$1.02B$3.58B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots